Network Pharmacology and Pharmacological Evaluation Reveals the Mechanism of the Sanguisorba Officinalis in Suppressing Hepatocellular Carcinoma

Network Pharmacology and Pharmacological Evaluation Reveals the Mechanism of the Sanguisorba Officinalis in Suppressing Hepatocellular Carcinoma

Background:Sanguisorba Officinalis L. (SO) is a well-known traditional Chinese medicine (TCM), commonly applied to treat complex diseases, such as anticancer, antibacterial, antiviral, anti-inflammatory, anti-oxidant and hemostatic effects. Especially, it has been reported to exert anti-tumor effect...

Full description

Bibliographic Details
Main Authors: Nan Jiang, Hong Li, Yueshan Sun, Jing Zeng, Fei Yang, Fahsai Kantawong, Jianming Wu
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-03-01
Series:Frontiers in Pharmacology
Subjects:
PI3K/Akt signal pathway
cell proliferation
network pharmacology
hepatocellular carcinoma
Sanguisorba officinalis L
EGFR/MAPK signaling
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2021.618522/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2021.618522/full

Similar Items